PFE Pfizer
- 29.600
- +1.040+3.64%
- 29.630
- +0.030+0.10%
Pfizer News
Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027
Pfizer Inc. (NYSE:PFE) has launched a multi-year cost-cutting initiative aimed at saving approximately $1.5 billion by the end of 2027.What Happened: The new program builds on a $4 billion cost reduct
Express News | Grey Wolf Therapeutics: Closed Oversubscribed $50 Mln Series B Financing Expansion, Bringing Total Funds Raised to $99 Mln
Pfizer's Hospira Recalls Select Hydrochloride Injection Carpuject Units
Wells Fargo Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $28
Wells Fargo analyst Mohit Bansal maintains $Pfizer(PFE.US)$ with a hold rating, and maintains the target price at $28.According to TipRanks data, the analyst has a success rate of 58.7% and a total av
BMO Capital Maintains Pfizer(PFE.US) With Buy Rating, Raises Target Price to $36
BMO Capital analyst Evan Seigerman maintains $Pfizer(PFE.US)$ with a buy rating, and adjusts the target price from $33 to $36.According to TipRanks data, the analyst has a success rate of 46.8% and a
Morgan Stanley Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $29
Morgan Stanley analyst Terence Flynn maintains $Pfizer(PFE.US)$ with a hold rating, and maintains the target price at $29.According to TipRanks data, the analyst has a success rate of 66.3% and a tota
Market Chatter: Asymchem Laboratories Buys Pfizer's Former UK Site; Hong Kong Shares Slide 3%
Asymchem Laboratories Tianjin (SHE:002821, HKG:6821) purchased Pfizer's research and development laboratory and production factory at the US pharmaceutical company's former Sandwich Site in the UK, Yi
Moderna, CureVac, Other Vaccine Stocks Jump as New Human Bird-flu Cases Reported in U.S., Australia
Vaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in the U.S. and Australia.
The spread of avian influenza sparks fears that US vaccine stocks such as Moderna (MRNA.US) rose sharply
US vaccine stocks rose sharply on Wednesday.
Pfizer (PFE.US) officially announces new “cost reduction and efficiency” plan: plans to save US$1.5 billion by 2027
Pfizer said Wednesday that the company has launched a new multi-year plan to reduce costs.
Pfizer, Moderna in Talks With HHS Over Avian Flu Vaccine: Report
Moderna, BioNTech Close With Double-digit Percentage Gains Amid Bird Flu Fears
Mega Options Trade Alert: Pfizer Spotting the Million-Dollar Moves
On May 22nd ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 348.42K options for the day, of which put options accounted for 30.23% of the total transactions, and call o
Express News | NYSE Order Imbalance 546430.0 Shares on Buy Side
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb
Shares of vaccine producers' stocks are trading higher Wednesday on reports indicating disease experts predict a small rise in COVID-19 cases this summer.The Details:According to a report from NBC New
COVID-19 Vaccine Makers Rebound Amid Post-pandemic Prospects
Pfizer Targets $1.5 Billion in Savings by 2027 as It Streamlines Operations
Express News | Pfizer Inc: One-Time Costs to Achieve Savings Associated With First Phase of Program Are Expected to Be About $1.7 Bln
Express News | Pfizer Inc - Costs Will Be Recorded Primarily in 2024, With Cash Outlays Expected in 2025 and 2026.
Express News | Pfizer Inc: First Phase of Multi-Year Program to Reduce Cost of Goods Sold Is Expected to Deliver Savings of Approximately $1.5 Bln by End of 2027
Analysis
Price Target
No Data
